Commentary

Video

Dr Weiss on the Role of Breast Imaging in Breast Cancer Treatment Decision-Making

Author(s):

Fact checked by:

Anna Weiss, MD, discusses the significance of various imaging modalities in patients with breast cancer.

“We’re finding more and more that axillary lymph node dissection can be avoided in many patients, especially those who undergo neoadjuvant therapy.”

Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine, discusses the significance of various imaging modalities in patients with breast cancer, as well as reasons for the declining role of axillary lymph node dissection in this disease.

Related Videos
David Schiff, MD
Timothy Gershon, MD, PhD
Jordan Hansford, MD
James J. Harding, MD, associate attending physician, Memorial Sloan Kettering Cancer Center
J. Bradley Elder, MD
Rimas V. Lukas, MD
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health
Diane Reidy-Lagunes, MD, vice chair, Oncology Operations, Regional Care Network, Memorial Sloan Kettering Cancer Center
Shubham Pant, MD, MBBS
Kevin Kalinsky, MD, MS, professor, Department of Hematology and Medical Oncology, director, Division of Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine; Louisa and Rand Glenn Family Chair in Breast Cancer Research, director, Glenn Family Breast Center, director, Breast Medical Oncology, Winship Cancer Institute of Emory University